Detalhe da pesquisa
1.
BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression.
Blood
; 137(6): 763-774, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33067633
2.
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
N Engl J Med
; 378(4): 331-344, 2018 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29224502
3.
Real-World Economic Burden Associated with Transplantation-Related Complications.
Biol Blood Marrow Transplant
; 23(10): 1788-1794, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28688917
4.
Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B.
N Engl J Med
; 369(24): 2313-23, 2013 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24304002
5.
Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.
Blood
; 123(3): 317-25, 2014 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-24227821
6.
Long-acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG study.
Br J Haematol
; 168(1): 124-34, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25208598
7.
Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients.
Blood
; 119(13): 3031-7, 2012 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-22223821
8.
Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients.
Blood
; 119(3): 666-72, 2012 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-22110246
9.
Proteomic analysis of the androgen receptor via MS-compatible purification of biotinylated protein on streptavidin resin.
Proteomics
; 12(1): 43-53, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22116683
10.
Suppression of the immune response to FVIII in hemophilia A mice by transgene modified tolerogenic dendritic cells.
Mol Ther
; 19(10): 1896-904, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21772255
11.
Results of genetic analysis of 11 341 participants enrolled in the My Life, Our Future hemophilia genotyping initiative in the United States.
J Thromb Haemost
; 20(9): 2022-2034, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35770352
12.
Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis.
Blood
; 113(8): 1778-85, 2009 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-18796624
13.
Suppression of FVIII inhibitor formation in hemophilic mice by delivery of transgene modified apoptotic fibroblasts.
Mol Ther
; 18(1): 214-22, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19755963
14.
Real-world economic burden of hematopoietic cell transplantation among a large US commercially insured population with hematologic malignancies.
J Med Econ
; 20(12): 1244-1251, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28782449
15.
Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative.
Blood Adv
; 1(13): 824-834, 2017 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29296726
16.
Transduction of long-term and mobilized peripheral blood-derived NOD/SCID repopulating cells by foamy virus vectors.
Hum Gene Ther
; 15(1): 87-92, 2004 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-14965380
17.
Acquired von Willebrand syndrome in a patient with monoclonal gammopathy of undetermined significance.
Blood Coagul Fibrinolysis
; 24(4): 430-2, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23249617
18.
Phenotypes of allo- and autoimmune antibody responses to FVIII characterized by surface plasmon resonance.
PLoS One
; 8(5): e61120, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23667433
19.
Production of foamy virus vector and transduction of hematopoietic cells.
Cold Spring Harb Protoc
; 2010(9): pdb.prot5481, 2010 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20810629
20.
Development of foamy virus vectors.
Methods Mol Med
; 76: 545-64, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12526184